Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives

Robert Hecht; Chutima Suraratdecha

doi:10.1371/journal.pmed.0030398

Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives

PLoS Med. 2006 Sep;3(10):e398. doi: 10.1371/journal.pmed.0030398.

Authors

Robert Hecht¹, Chutima Suraratdecha

Affiliation

¹ International AIDS Vaccine Initiative, New York, New York, USA. rhecht@iavi.org

Abstract

Additional research on public and private demand for HIV vaccines is needed to strengthen ongoing advocacy and planning for eventual vaccine introduction, say Hecht and Suraratdecha.

MeSH terms

AIDS Vaccines / economics
AIDS Vaccines / supply & distribution*
Developing Countries / economics
Global Health*
HIV Infections / economics
HIV Infections / prevention & control*
Health Care Costs
Health Policy*
Health Services Needs and Demand*
Humans
International Cooperation
Patient Acceptance of Health Care
Private Sector / economics
Public Sector / economics

Substances

AIDS Vaccines